3-10087244-C-T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001018115.3(FANCD2):c.3446C>T(p.Ala1149Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000371 in 1,605,114 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1149G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001018115.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001018115.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCD2 | NM_001018115.3 | MANE Select | c.3446C>T | p.Ala1149Val | missense | Exon 34 of 44 | NP_001018125.1 | ||
| FANCD2 | NM_033084.6 | c.3446C>T | p.Ala1149Val | missense | Exon 34 of 43 | NP_149075.2 | |||
| FANCD2 | NM_001374254.1 | c.3446C>T | p.Ala1149Val | missense | Exon 34 of 42 | NP_001361183.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FANCD2 | ENST00000675286.1 | MANE Select | c.3446C>T | p.Ala1149Val | missense | Exon 34 of 44 | ENSP00000502379.1 | ||
| FANCD2 | ENST00000287647.7 | TSL:1 | c.3446C>T | p.Ala1149Val | missense | Exon 34 of 43 | ENSP00000287647.3 | ||
| FANCD2 | ENST00000419585.5 | TSL:1 | c.3446C>T | p.Ala1149Val | missense | Exon 34 of 44 | ENSP00000398754.1 |
Frequencies
GnomAD3 genomes AF: 0.000691 AC: 102AN: 147552Hom.: 2 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00125 AC: 314AN: 251104 AF XY: 0.00101 show subpopulations
GnomAD4 exome AF: 0.000339 AC: 494AN: 1457540Hom.: 6 Cov.: 34 AF XY: 0.000268 AC XY: 194AN XY: 725172 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000691 AC: 102AN: 147574Hom.: 2 Cov.: 31 AF XY: 0.000739 AC XY: 53AN XY: 71718 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
FANCD2: BP4, BS1, BS2
not specified Benign:1Other:1
The FANCD2 p.Ala1149Val variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs147675860), ClinVar (classified as a VUS by Illumina for Fanconi Anemia, likely benign by Center for Pediatric Genomic Medicine at Children's Mercy Hospital and Clinics and benign by Invitae for Fanconi Anemia) and Cosmic (FATHMM prediction: neutral; score=0.19). The variant was identified in control databases in 352 of 281318 chromosomes (5 homozygous) at a frequency of 0.001251 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: East Asian in 320 of 19928 chromosomes (freq: 0.01606), African in 22 of 24706 chromosomes (freq: 0.000891), Other in 2 of 7158 chromosomes (freq: 0.000279), Latino in 2 of 35354 chromosomes (freq: 0.000057), European (non-Finnish) in 5 of 128722 chromosomes (freq: 0.000039) and South Asian in 1 of 30612 chromosomes (freq: 0.000033), but was not observed in the Ashkenazi Jewish or European (Finnish) populations. The p.Ala1149 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign.
Fanconi anemia complementation group D2 Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Fanconi anemia Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at